Brokerages Set Teva Pharmaceutical Industries Limited (NYSE:TEVA) Price Target at $23.57
Shares of Teva Pharmaceutical Industries Limited (NYSE:TEVA – Get Free Report) have been assigned an average rating of “Moderate Buy” from the seven ratings firms that are presently covering the firm, Marketbeat Ratings reports. One equities research analyst has rated the stock with a hold recommendation and six have given a buy recommendation to the […]
Shares of Teva Pharmaceutical Industries Limited (NYSE:TEVA – Get Free Report) have been assigned an average rating of “Moderate Buy” from the seven ratings firms that are presently covering the firm, Marketbeat Ratings reports. One equities research analyst has rated the stock with a hold recommendation and six have given a buy recommendation to the […]
